Ataraxis AI
Ataraxis AI is a precision oncology company that develops AI-based prognostic and predictive tests for oncology. Its flagship platform, Ataraxis Breast, uses AI to predict recurrence risk, chemotherapy benefit, and neoadjuvant treatment response in all breast cancer subtypes.
About Ataraxis AI
Ataraxis AI is a precision oncology company that develops AI-based prognostic and predictive tests for oncology. Its flagship platform, Ataraxis Breast, uses AI to predict recurrence risk, chemotherapy benefit, and neoadjuvant treatment response in all breast cancer subtypes.
Products
AI-native platform with clinically validated prognostic and predictive tools for breast cancer, including recurrence risk, chemotherapy benefit, and neoadjuvant response predict...
AI pathology foundation model trained with hundreds-of-millions of pan-cancer pathology slide images, extracting novel information about tumor morphology correlated with patient...
Security and compliance
As reported by Ataraxis AI. Ask for audit reports before you buy.
- HIPAACompliant
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Ataraxis AI